Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas
ABSTRACT Background Bispecific antibodies are effective for relapsed/refractory B‐cell lymphoma patients even after CAR‐T therapy. Methods Peripheral blood CAR‐T kinetics and functional analysis in vivo were carried out pre‐ and post‐epcoritamab infusion in B‐cell lymphoma patients relapsing after C...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2025-06-01
|
| Serie: | eJHaem |
| Accesso online: | https://doi.org/10.1002/jha2.70079 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|